Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl] 5- methylisoxazole-4-carboxamide

Clinical Cancer Research

Volumn 3, Issue 7, 1997, Pages 1167-1177

  Shawver, Laura K ^a   Schwartz, Donna P ^a   Mann, Elaina ^a   Chen, Hui ^a   Tsai, Jianming ^a   Chu, Lillian ^a   Taylorson, Lesley ^a   Longhi, Michael ^a   Meredith, Shelly ^a   Germain, Linda ^a,b   Jacobs, Jolanta S ^a   Tang, Cho ^a   Ullrich, Axel ^c   Berens, Michael E ^d   Hersh, Evan ^e   McMahon, Gerald ^a   Hirth, K Peter ^a   Powell, T J ^a  

^a SUGEN INC   (United States)

^b INCSTAR Corporation ^*  (United States)

^c MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^d BARROW NEUROLOGICAL INSTITUTE   (United States)

^e UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; LEFLUNOMIDE; PLATELET DERIVED GROWTH FACTOR; UNCLASSIFIED DRUG;

ARTICLE; AUTOCRINE EFFECT; CANCER INHIBITION; CANCER SURVIVAL; DNA SYNTHESIS INHIBITION; DRUG EFFECT; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

3T3 CELLS; ANIMALS; BRAIN NEOPLASMS; CELL SURVIVAL; EPIDERMAL GROWTH FACTOR; FEMALE; GLIOMA; GROWTH INHIBITORS; HUMANS; ISOXAZOLES; MALE; MICE; MICE, INBRED C57BL; MICE, NUDE; OVARIAN NEOPLASMS; PLATELET-DERIVED GROWTH FACTOR; PROSTATIC NEOPLASMS; RATS; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0030811256     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Amagi, M., Ozawa, S., Ueda, M., Nishikawa, T., Abe. O., and Shimizu, N. Distribution of EGF receptor expressing and DNA replicating epidermal cells in psoriasis vulgaris and Bowen's disease. Br. J. Dermatol., 119: 661-668, 1988.
2. King, L. E., Gates, R. E., Stoscheck, C. M., and Nannery, L. B. Epidermal growth factor/transforming growth factor α receptors and psoriasis. J. Invest. Dermatol., 95: 10S-12S, 1990.
3. Elder, J. T., Klein, S. B., Tavakkol, A., Fisher, G. J., Nickoloff, B. J., and Voorhees, J. J. Growth factor and proto-oncogene expression in psoriasis. J. Invest. Dermatol., 95: 7S-9S, 1990.
4. Kahn, C. R. Insulin action, diabetogenes, and the cause of Type II diabetes. Diabetes, 43: 1066-1084, 1994.
5. Caro, J. F. Biochemical defects of insulin action in humans. In: D. LeRoith, S. I. Taylor, and J. M. Olefsky (eds.). Diabetes Mellitus: A Fundamental and Clinical Text. pp. 519-529. Philadelphia: Lippincott-Raven Publishers, 1996.
6. Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., and McGuire, W. L. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science (Washington DC), 235: 177-182, 1987.
7. Plowman, G. D., Ullrich, A., and Shawver, L. K. Receptor tyrosine kinases as targets for drug intervention. Drug News Perspect., 7: 334-339, 1994.
8. Plate, K. H., Breier, G., Farrell, C. L., and Risau, W. Platelet-derived growth factor receptor-β is induced during tumor development and upregulated during tumor progression in endothelial cells in human gliomas. Lab. Invest., 67: 529-534, 1992.
9. Hermanson, M., Funa, K., Hartman, M., Claesson-Welsh, L., Heldin, C. H., Westermark, B., and Nister, M. Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res., 52: 3213-3219, 1992.
10. Nister, M., Claesson-Welsh, L., Eriksson, A., Heldin, C. H., and Westermark, B. Differential expression of platelet-derived growth factor receptors in human malignant glioma cell lines. J. Biol. Chem., 266: 16755-16763, 1991.
11. Nister, M., Libermann, T. A., Betsholtz, C., Pettersson, M., Claesson-Welsh, L., Heldin, C. H., Schlessinger, J., and Westermark, B. Expression of messenger RNAs for platelet-derived growth factor and transforming growth factor-α and their receptors in human malignant glioma cell lines. Cancer Res., 48: 3910-3918, 1988.
12. Habenicht, A. J. R., Salbach, P., Janben-Timmen, U., Blattner, C., and Schettler, G. Platelet-derived growth factor-a growth factor with an expanding role in health and disease. Klin. Wochenschr., 68: 53-59, 1990.
13. Heldin, C. H. Structural and functional studies on platelet-derived growth factor. EMBO J., 11: 4251-4259, 1992.
14. Ullrich, A., and Schlessinger, J. Signal transduction by receptors with tyrosine kinase activity. Cell, 61: 203-212, 1990.
15. Schlessinger, J., and Ullrich, A. Growth factor signaling receptor tyrosine kinases. Neuron, 9: 383-391, 1992.
16. Strawn, L. M., Mann, E., Elliger, S. S., Chu, L. M., Germain, L. L., Niederfellner, G., Ullrich, A., and Shawver, L. K. Inhibition of glioma cell growth by a truncated platelet-derived growth factor-β receptor. J. Biol. Chem., 269: 21215-21222, 1994.
17. Strawn, L. M., McMahon, G., App, H., Schreck, R., Kuchler, W. R., Longhi, M. P., Hui, T. H., Tang, C, Levitzki, A., Gazit, A., Chen, I., Ken, G., Orfi, L., Risau, W., Flamme, I., Ullrich, A., Hirth, K. P., and Shawver, L. K. Flk-1 as a target for tumor growth inhibition. Cancer Res., 56: 3540-3545, 1996.
18. Skehan, P., Storeng, R., Schudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenney, S., and Boyd, M. R. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst., 82: 1107-1112, 1990.
19. Henriksen, R., Funa, K., Wilander, E., Backstrom, T., Ridderheim, M., and Oberg, K. Expression and prognostic significance of platelet-derived growth factor and its receptors in epithelial ovarian neoplasms. Cancer Res., 53: 4550-4554, 1993.
20. Antoniades, H. N., Galanopoulos, T., Neville-Golden, J., and O'Hara, C. J. Malignant epithelial cells in primary human lung carcinomas coexpress in vivo platelet-derived growth factor (PDGF) and PDGF receptor mRNAs and their protein products. Proc. Natl. Acad. Sci. USA, 89: 3942-3946, 1992.
21. Krasagakis, K., Garbe, C., and Orfanos, C. E. Cytokines in human melanoma cells: synthesis, autocrine stimulation and regulatory functions - an overview. Melanoma Res., 3: 425-433, 1993.
22. Lindmark, G., Sundberg, C., Glimelius, B., Phalman, L., Rubin, K., and Gerdin, B. Stromal expression of platelet-derived growth factor β-receptor and platelet-derived growth factor B-chain in colorectal cancer. Lab. Invest., 69: 682-689, 1993.
23. Story, M. T. Polypeptide modulators of prostatic growth and development. Cancer Surv., 11: 123-146, 1991.
24. Chung, C. K., and Antoniades, H. N. Expression of c-sis/platelet-derived growth factor B. insulin-like growth factor I, and transforming growth factor a messenger RNAs and their respective receptor messenger RNAs in primary human gastric carcinomas: in vivo studies with in situ hybridization and immunohistochemistry. Cancer Res., 52: 3453-3459, 1992.
25. Seymour, L., Dajee, D., and Bezwoda, W. R. Tissue platelet derived-growth factor (PDGF) predicts for shortened survival and treatment failure in advanced breast cancer. Breast Cancer Res. Treat., 26: 247-252, 1993.
26. Holmgren, L., Flan, F., Larsson, E., and Ohlsson, R. Successive activation of the platelet-derived growth factor β receptor and platelet-derived growth factor B genes correlates with genesis of human choriocarcinoma. Cancer Res., 53: 2927-2941, 1993.
27. Yoshida, K., Kuniyasu, H., Yasui, W., Kitadai, Y., Toge, T., and Tahara, E. Expression of growth factors and their receptors in human esophageal carcinomas: regulation of expression by epidermal growth factor and transforming growth factor α. Cancer Res. Clin. Oncol., 199: 401-407, 1993.
28. Wang, J., Coltrera, D., and Gown, A. M. Cell proliferation in human soft tissue tumors correlates with platelet-derived growth factor B chain expression: an immunohistochemical and in situ hybridization study. Cancer Res., 54: 560-564, 1994.
29. Sturzl, M., Roth, W. K., Brockmeyer, N. H., Zietz, C., Speiser, B., and Hofschneider, P. H. Expression of platelet-derived growth factor and its receptor in AIDS-related Kaposi sarcoma in vivo suggests paracrine and autocrine mechanisms of tumor maintenance. Proc. Natl. Acad. Sci. USA, 89: 7046-7050, 1992.
30. Brouty-Boye, D., and Magnien, V. Myofibroblast and concurrent ED-β fibronectin phenotype in human stromal cells cultured from non-malignant and malignant breast tissue. Eur. J. Cancer, 30A: 66-73, 1994.
31. Ponten, F., Ren, Z., Nister, M., Westermark, B., and Ponten, J. Epithelial-stromal interactions in basal cell cancer: the PDGF system. Invest. Dermatol., 702: 304-309, 1994.
32. Forsberg, K., Valyi-Nagy, I., Heldin, C. H., Herlyn, M., and Westermark, B. Platelet-derived growth factor (PDGF) in oncogenesis: development of a vascular connective tissue stroma in xenotransplanted human melanoma producing PDGF-BB. Proc. Natl. Acad. Sci. USA, 90: 393-397, 1993.
33. Westermark, B., and Heldin, C. H. Platelet-derived growth factor. Structure, function and implications in normal and malignant cell growth. Acta Oncol., 32: 101-105, 1993.
34. Terman, B. I., Carrion, M. E., Kovacs, E., Rasmussen, B. A., Eddy, R. L., and Shows, T. B. Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene, 6: 1677-1683, 1991.
35. Williamson, R. A., Yea, C. M., Robson, P. A., Curnock, A. P., Gadher, S., Hambleton, A. B., Woodward, K., Bruneau, J-M., Hambleton, P., Moss, D., Thomson, T. A., Spinella-Jaegle, S., Morand, P., Courtin, O., Sautes, C., Westwood, R., Hercend, T., Kuo, E. A., and Ruuth, E. Dihydroorotate dehydrogenase is a high affinity binding protein for A77 1726 and mediator of a range of biological effects of the immunomodulatory compound. J. Biol. Chem., 270: 22467-22472, 1995.
36. Cherwinski, H. M., Byars, N., Ballaron, S. J., Nakano, G. M., Young, J. M., and Ranson, J. T. Leflunomide interferes with pyrimidine nucleotide biosynthesis. Inflammation Res., 44: 317-322, 1995.
37. Williamson, R. A., Yea, C. M., Robson, P. A., Curnock, A. P., Gadher, S., Hambleton, A. B., Woodward, K., Bruneau, J-M., Hambleton, P., Moss, D., Thomson, T. A., Spinella-Jaegle, S., Morand, P., Courtin, O., Sautes, C., Westwood, R., Hereend, T., Kuo, E. A., and Ruuth, E. Dihydroorotate dehydrogenase is a high affinity binding protein for A77 1726 and mediator of a range of biological effects of the immunomodulatory compound. J. Biol. Chem., 270: 22467-22472, 1995.
38. Davis, J. P., Cain, G. A., Pitts, W. J., Magolda, R. L., and Copeland, R. A. The immunosuppressive metabolite of leflunomide is a potent inhibitor of human dihydroorotate dehydrogenase. Biochemistry, 35: 1270-1273, 1996.
39. Mattar, T., Kochlar, K., Bartlett, R., Bremen E. G., and Finnegan, A. Inhibition of the epidermal growth factor receptor tyrosine kinase activity by leflunomide. FEBS Lett., 334: 161-164, 1993.
40. Bartlett, R. R., Dimitrijevic, M., Mattar, T., Zielinski, T., Germann, T., Rüde, E., Thoenes, G. H., Küchle, C. C. A., Schorlemmer, H-U., Bremer, E., Finnegan, A., and Schleyerbach, R. Leflunomide (HWA486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejection. Agents Actions, 32: 10-21, 1991.
41. Chong, A. S-F., Finnegan, A., Jiang, X., Gebel, H., Sankary, H. N., Foster, P., and Williams, J. W. Leflunomide, a novel immunosuppressive agent: the mechanism of inhibition of T-cell proliferation. Transplantation (Baltimore), 55: 1361-1366, 1993.
42. Pasternak, R., D., Wadopian, N. S., Wright, R. N., Siminoff, P., and Buyniski, J. P. Disease modifying activity of HWA 486 in rat adjuvant-induced arthritis. Agents Actions, 21: 241-243, 1987.
43. Bartlett, R. R. Immunopharmacological profile of a novel isoxazole derivative, HWA 486, with potential antirheumatic activity-II. In vivo immunomodulating effects differ from those of cyclophosphamide, prednisolone, or cyclosporin A. Int. J. Immunopharmacol. 8: 199-204, 1996.
44. Bartlett, R. R., and Schleyerbach, R. Immunopharmacological profile of a novel isoxazole derivative, HWA 486. with potential antirheumatic activity-I. Disease modifying action on adjuvant arthritis of the rat. Int. J. Immunopharmacol., 7: 7-18, 1985.
45. Plate, K. H., Breier, G., Farrell, C. L., and Risau, W. Platelet-derived growth factor receptor-β is induced during tumor development and upregulated during tumor progression in endothelial cells in human gliomas. Lab. Invest., 67: 529-534, 1992.
46. Jahroudi, N., and Greenberger, J. S. The role of endothelial cells in tumor invasion and metastasis. J. Neurooncol., 23: 99-108, 1995.